P. H. Lagrange

1.0k total citations
58 papers, 803 citations indexed

About

P. H. Lagrange is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, P. H. Lagrange has authored 58 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 21 papers in Infectious Diseases and 11 papers in Immunology. Recurrent topics in P. H. Lagrange's work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (13 papers) and Antibiotic Resistance in Bacteria (10 papers). P. H. Lagrange is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (13 papers) and Antibiotic Resistance in Bacteria (10 papers). P. H. Lagrange collaborates with scholars based in France, Brazil and Vietnam. P. H. Lagrange's co-authors include Guillaume Arlet, A. Philippon, Jean‐Louis Herrmann, Olivier Gaillot, G. Brami, J. F. Acar, F. W. Goldstein, Bruno Hurtrel, Salvatore Costa and I Casin and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

P. H. Lagrange

57 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. H. Lagrange France 13 376 269 251 163 144 58 803
A Buré France 14 433 1.2× 312 1.2× 270 1.1× 140 0.9× 145 1.0× 45 884
Moon Won Kang South Korea 15 278 0.7× 240 0.9× 303 1.2× 221 1.4× 118 0.8× 34 789
Elizabeth T. S. Houang United Kingdom 16 417 1.1× 191 0.7× 176 0.7× 216 1.3× 307 2.1× 30 1.0k
Kathrine Dornbusch Sweden 14 370 1.0× 153 0.6× 242 1.0× 160 1.0× 139 1.0× 41 754
E. Bordi Italy 16 340 0.9× 277 1.0× 258 1.0× 93 0.6× 96 0.7× 29 779
J. Croizé France 20 430 1.1× 318 1.2× 219 0.9× 307 1.9× 200 1.4× 78 1.2k
Deborah Gascoyne‐Binzi United Kingdom 16 347 0.9× 367 1.4× 334 1.3× 169 1.0× 187 1.3× 25 891
Matthew E. Griffith United States 17 315 0.8× 249 0.9× 291 1.2× 195 1.2× 132 0.9× 27 932
Françoise Chau France 18 346 0.9× 314 1.2× 330 1.3× 214 1.3× 112 0.8× 46 912
Joseph R. DiPersio United States 18 302 0.8× 357 1.3× 520 2.1× 180 1.1× 117 0.8× 37 1.1k

Countries citing papers authored by P. H. Lagrange

Since Specialization
Citations

This map shows the geographic impact of P. H. Lagrange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. H. Lagrange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. H. Lagrange more than expected).

Fields of papers citing papers by P. H. Lagrange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. H. Lagrange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. H. Lagrange. The network helps show where P. H. Lagrange may publish in the future.

Co-authorship network of co-authors of P. H. Lagrange

This figure shows the co-authorship network connecting the top 25 collaborators of P. H. Lagrange. A scholar is included among the top collaborators of P. H. Lagrange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. H. Lagrange. P. H. Lagrange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herrmann, Jean‐Louis, Anne Bergeron, Raphaël Porcher, et al.. (2008). IFNγ and antibody responses among French nurses during a tuberculosis contact tracing investigation. Pathologie Biologie. 57(3). e49–e53. 14 indexed citations
2.
3.
Sasportes, M, et al.. (2005). Granulysine : médiateur de l'immunité innée et de l'immunité acquise dans la tuberculose chez l'homme. Pathologie Biologie. 53(8-9). 516–521. 3 indexed citations
4.
Tomimori‐Yamashita, Jane, et al.. (1999). Antibody-based enzyme-linked immunosorbent assay for determination of anti-PGL-I specific circulating immune complex in leprosy patients. Leprosy Review. 70(3). 261–71. 2 indexed citations
5.
Ternynck, Thérèse, et al.. (1996). Recycling of ELISA plates for the serological diagnosis of tuberculosis using a Mycobacterium tuberculosis-specific glycolipid antigen. Journal of Immunological Methods. 199(1). 101–105. 5 indexed citations
6.
Arlet, Guillaume, et al.. (1995). Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiology Letters. 134(2-3). 203–208. 153 indexed citations
7.
Fitoussi, F., Guillaume Arlet, Patrick A. D. Grimont, P. H. Lagrange, & A. Philippon. (1995). Escherichia hermannii: susceptibility pattern to β-lactams and production of β-lactamase. Journal of Antimicrobial Chemotherapy. 36(3). 537–543. 10 indexed citations
8.
Philippon, A., Guillaume Arlet, & P. H. Lagrange. (1994). Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. European Journal of Clinical Microbiology & Infectious Diseases. 13(S1). S17–S29. 129 indexed citations
9.
Arlet, Guillaume, A. Philippon, I Casin, & P. H. Lagrange. (1994). Rochalimaea : de l'angiomatose bacillaire à la maladie des griffes du chat. Médecine et Maladies Infectieuses. 24(3). 227–240. 5 indexed citations
10.
Calabrese, Kátia da Silva, et al.. (1992). Trypanosoma cruzi infection in immunosuppressed mice. Immunology Letters. 31(1). 91–96. 9 indexed citations
11.
Herrmann, Jean‐Louis & P. H. Lagrange. (1992). Intracellular activity of zidovudine (3'-azido-3'-deoxythymidine, AZT) against Salmonella typhimurium in the macrophage cell line J774-2. Antimicrobial Agents and Chemotherapy. 36(5). 1081–1085. 11 indexed citations
12.
Scieux, Catherine, A Bianchi, Stanley C. Henry, et al.. (1992). Evaluation of a chemiluminometric immunoassay for detection ofChlamydia trachomatis in the urine of male and female patients. European Journal of Clinical Microbiology & Infectious Diseases. 11(8). 704–708. 2 indexed citations
13.
Lagrange, P. H., et al.. (1986). Trypanosoma cruzi invasion of structures related to development and central nervous system. 22(6). 183–190. 12 indexed citations
14.
Lagrange, P. H.. (1984). La vaccination préventive contre la tuberculose: le BCG. 31(6). 3220–3227. 1 indexed citations
15.
Costa, Salvatore, et al.. (1984). Role of T lymphocytes in the resistance and immunopathology of experimental chagas' disease. Annales de l Institut Pasteur Immunologie. 135(3). 317–332. 24 indexed citations
16.
Michel, Jean‐Claude, Bruno Hurtrel, & P. H. Lagrange. (1982). Inflammation and resistance of mice against Plasmodium berghei.. Annales de l Institut Pasteur Immunologie. 97–101. 1 indexed citations
17.
Hurtrel, Bruno & P. H. Lagrange. (1978). Réactions d'hypersensibilité de type retardé induites par Candida albicans chez la souris.. Annales de l Institut Pasteur Immunologie. 3 indexed citations
18.
Lagrange, P. H.. (1976). [Regulation mechanisms of the activity of T lymphocytes : applications to infective and tumoral pathology. II. -- BCG and immuno-stimulation (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24(2). 153–9. 1 indexed citations
19.
Lagrange, P. H.. (1976). [Regulation mechanisms of the activity of T lymphocytes. Applications to infective and tumoral pathology. I. Delayed hypersensitivity and humoral response (author's transl)].. PubMed. 24(1). 67–74. 3 indexed citations
20.
Lagrange, P. H., et al.. (1971). Vaccination antigrippale chez les insuffisants rénaux traités par hémodialyse périodique et chez les sujets ayant subi une transplantation rénale.. Bulletin de l Académie Nationale de Médecine. 155(30). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Buré Breakdown of academic impact, for papers by Moon Won Kang Breakdown of academic impact, for papers by Elizabeth T. S. Houang Breakdown of academic impact, for papers by Kathrine Dornbusch Breakdown of academic impact, for papers by E. Bordi Breakdown of academic impact, for papers by J. Croizé Breakdown of academic impact, for papers by Deborah Gascoyne‐Binzi Breakdown of academic impact, for papers by Matthew E. Griffith Breakdown of academic impact, for papers by Françoise Chau Breakdown of academic impact, for papers by Joseph R. DiPersio
Rankless by CCL
2026